merozoite surface antigen 1
Naturally acquired cellular immune response against Plasmodium vivax merozoite surface protein 1 paralog antigen
9
Spherical Body Protein 4 Is a New Serological Antigen for Global Detection of Babesia bovis Infection in Cattle
6
Antibody responses to, and the structure of Plasmodium falciparum merozoite surface protein-1: A candidate malaria vaccine antigen
236
Prediction of Merozoite Surface Protein 1 and Apical Membrane Antigen 1 Vaccine Efficacies against Plasmodium chabaudi Malaria Based on Prechallenge Antibody Responses
10
Immunogenetic markers associated with a naturally acquired humoral immune response against an N terminal antigen of Plasmodium vivax merozoite surface protein 1 (PvMSP 1)
11
Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein 1 C terminal 19kD (MSP1 19kD), in Peruvians exposed to hypoendemic malaria transmission
11
Genetic polymorphism of merozoite surface protein 1 and merozoite surface protein 2 in Plasmodium falciparum field isolates from Myanmar
8
Conformational Dependence and Conservation of an Immunodominant Epitope within the Babesia equi Erythrocyte-Stage Surface Protein Equi Merozoite Antigen 1
6
Expression of Babesia equi Merozoite Antigen 1 in Insect Cells by Recombinant Baculovirus and Evaluation of Its Diagnostic Potential in an Enzyme Linked Immunosorbent Assay
5
Molecular identification and antigenic characterization of a merozoite surface antigen and a secreted antigen of Babesia canis (BcMSA1 and BcSA1)
11
Variation in the immune responses against Plasmodium falciparum merozoite surface protein 1 and apical membrane antigen 1 in children residing in the different epidemiological strata of malaria in Cameroon
14
Identification of a novel merozoite surface antigen of Plasmodium vivax, PvMSA180
10
Interferon gamma responses to Plasmodium falciparum liver stage antigen 1 and merozoite surface protein 1 increase with age in children in a malaria holoendemic area of western Kenya
7
Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein 1 (MSP142) administered intramuscularly with adjuvant system AS01
13
Comparative analysis of the profiles of IgG subclass specific responses to Plasmodium falciparum apical membrane antigen 1 and merozoite surface protein 1 in naturally exposed individuals living in malaria hypoendemic settings, Iran
14
IMMUNOGENICITY OF THE MEROZOITE SURFACE PROTEIN-1 (MSP-1) OF HUMAN PLASMODIUM SP.
7
Genetic diversity of the msp 1, msp 2, and glurp genes of Plasmodium falciparum isolates in Northwest Ethiopia
8
PCR/RFLP Based Analysis of Genetically Distinct Plasmodium vivax Population of Pvmsp 3α and Pvmsp 3β genes in Pakistan
7
Genetic polymorphism of merozoite surface protein 1 and merozoite surface protein 2 in Plasmodium falciparum isolates from Brazzaville, Republic of Congo
7
In vitro invasion inhibition assay using antibodies against Plasmodium knowlesi Duffy binding protein alpha and apical membrane antigen protein 1 in human erythrocyte adapted P knowlesi A1 H 1 strain
11